End-of-day quote
Shanghai S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
16.97
CNY
|
-2.13%
|
|
+1.31%
|
-2.47%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,139
|
6,115
|
12,213
|
13,461
|
7,717
|
7,308
|
-
|
-
|
Enterprise Value (EV)
1 |
6,139
|
6,115
|
12,213
|
13,461
|
7,717
|
7,308
|
7,308
|
7,308
|
P/E ratio
|
20.5
x
|
18.3
x
|
15
x
|
7.2
x
|
26.6
x
|
18.4
x
|
13.2
x
|
11.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.28
x
|
1.19
x
|
1.88
x
|
-
|
1.52
x
|
1.16
x
|
1.02
x
|
0.95
x
|
EV / Revenue
|
1.28
x
|
1.19
x
|
1.88
x
|
-
|
1.52
x
|
1.16
x
|
1.02
x
|
0.95
x
|
EV / EBITDA
|
-
|
9.99
x
|
-
|
-
|
13
x
|
10.1
x
|
7.88
x
|
6.85
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
3.09
x
|
5.2
x
|
-
|
2.15
x
|
1.88
x
|
1.66
x
|
1.45
x
|
Nbr of stocks (in thousands)
|
430,650
|
430,650
|
430,650
|
442,782
|
443,483
|
430,650
|
-
|
-
|
Reference price
2 |
14.26
|
14.20
|
28.36
|
30.40
|
17.40
|
16.97
|
16.97
|
16.97
|
Announcement Date
|
4/20/20
|
4/19/21
|
4/18/22
|
4/17/23
|
4/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,781
|
5,121
|
6,484
|
-
|
5,086
|
6,276
|
7,140
|
7,655
|
EBITDA
1 |
-
|
612.4
|
-
|
-
|
594.7
|
723
|
927
|
1,067
|
EBIT
1 |
-
|
406.6
|
1,013
|
-
|
349.5
|
505
|
690.5
|
683.5
|
Operating Margin
|
-
|
7.94%
|
15.62%
|
-
|
6.87%
|
8.05%
|
9.67%
|
8.93%
|
Earnings before Tax (EBT)
1 |
-
|
388.8
|
984.8
|
-
|
341
|
491
|
681.5
|
808
|
Net income
1 |
-
|
334.9
|
816.5
|
1,844
|
283
|
410
|
569.5
|
676.5
|
Net margin
|
-
|
6.54%
|
12.59%
|
-
|
5.56%
|
6.53%
|
7.98%
|
8.84%
|
EPS
2 |
0.6968
|
0.7777
|
1.896
|
4.225
|
0.6542
|
0.9200
|
1.285
|
1.525
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/20/20
|
4/19/21
|
4/18/22
|
4/17/23
|
4/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
16.3%
|
36.7%
|
60.9%
|
8.14%
|
10.2%
|
12.6%
|
13.1%
|
ROA (Net income/ Total Assets)
|
-
|
7.53%
|
-
|
-
|
-
|
5.8%
|
7.3%
|
7.9%
|
Assets
1 |
-
|
4,451
|
-
|
-
|
-
|
7,069
|
7,801
|
8,563
|
Book Value Per Share
2 |
-
|
4.590
|
5.450
|
-
|
8.100
|
9.020
|
10.20
|
11.70
|
Cash Flow per Share
2 |
-
|
1.640
|
2.310
|
-
|
1.740
|
1.070
|
2.060
|
-
|
Capex
1 |
-
|
198
|
-
|
-
|
455
|
265
|
267
|
269
|
Capex / Sales
|
-
|
3.86%
|
-
|
-
|
8.95%
|
4.21%
|
3.74%
|
3.51%
|
Announcement Date
|
4/20/20
|
4/19/21
|
4/18/22
|
4/17/23
|
4/22/24
|
-
|
-
|
-
|
Last Close Price
16.97
CNY Average target price
21
CNY Spread / Average Target +23.75% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.47% | 1.01B | | +3.34% | 3.67B | | -20.60% | 2.14B | | -6.63% | 1.99B | | +5.93% | 1.94B | | +0.77% | 1.72B | | +5.69% | 1.21B | | -18.21% | 1.08B | | -8.04% | 906M | | -6.77% | 750M |
Pesticide
|